State of Wisconsin Investment Board’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,823
Closed -$480K 2287
2024
Q3
$480K Hold
16,823
﹤0.01% 1891
2024
Q2
$366K Sell
16,823
-819
-5% -$18.3K ﹤0.01% 1965
2024
Q1
$391K Sell
17,642
-2,273
-11% -$49.5K ﹤0.01% 1870
2023
Q4
$430K Buy
+19,915
New +$351K ﹤0.01% 1838
2022
Q2
Sell
-16,400
Closed -$736K 2820
2022
Q1
$736K Hold
16,400
﹤0.01% 1709
2021
Q4
$703K Sell
16,400
-4,900
-23% -$256K ﹤0.01% 1562
2021
Q3
$1.42M Hold
21,300
﹤0.01% 1359
2021
Q2
$1.56M Hold
21,300
﹤0.01% 1338
2021
Q1
$1.46M Buy
21,300
+4,900
+30% +$368K ﹤0.01% 1286
2020
Q4
$1.1M Buy
16,400
+1,800
+12% +$97.6K ﹤0.01% 1305
2020
Q3
$751K Hold
14,600
﹤0.01% 1362
2020
Q2
$550K Hold
14,600
﹤0.01% 1398
2020
Q1
$435K Buy
+14,600
New +$441K ﹤0.01% 1379

Other funds holding CSTL

State of Wisconsin Investment Board's CSTL Position: Q4 2024 in Review

State of Wisconsin Investment Board sold out of Castle Biosciences (CSTL) in Q4 2024, closing a stake of 16,823 shares — an estimated $480K sold.

State of Wisconsin Investment Board first reported a position in CSTL in Q1 2020 and held it in 13 quarters. The position peaked at $1.56M in Q2 2021. 197 funds tracked by Wall St. Rank hold CSTL as of Q4 2024.

  • State of Wisconsin Investment Board reported no remaining Castle Biosciences position as of Q4 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 16,823 Castle Biosciences shares in Q4 2024, an estimated $480K.
  • State of Wisconsin Investment Board first reported a position in Castle Biosciences in Q1 2020 and held it in 13 quarters.
  • State of Wisconsin Investment Board's Castle Biosciences position peaked at $1.56M in Q2 2021.
  • 197 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2024, filed 14 Feb 2025.